AAAAAA
Results:
1-14
|
Results: 14
Authors:
Dhanikula, AB
Panchagnula, R
Singh, I
Kaur, KJ
Kaul, CL
Sekhon, JS
Citation: Ab. Dhanikula et al., Pharmacokinetic study of paclitaxel as a 3-hour infusion in an Indian population: 135 mg/m(2) vs. 175 mg/m(2), METH FIND E, 23(2), 2001, pp. 93-98
Authors:
Agrawal, S
Kaul, CL
Panchagnula, R
Citation: S. Agrawal et al., Bioequivalence of isoniazid in a two drug fixed dose combination and in a single drug dosage form, PHARMAZIE, 56(8), 2001, pp. 636-639
Authors:
Gandhi, R
Sharma, P
Chawla, HPS
Kaul, CL
Panchagnula, R
Citation: R. Gandhi et al., HPLC analysis of tricyclic antidepressants in skin diffusion studies, STP PHARM S, 10(3), 2000, pp. 234-238
Authors:
Panchagnula, R
Agrawal, S
Kaur, KJ
Singh, I
Kaul, CL
Citation: R. Panchagnula et al., Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol, INT J TUBE, 4(12), 2000, pp. 1169-1172
Authors:
Gandhi, R
Kaul, CL
Panchagnula, R
Citation: R. Gandhi et al., Validated LC method for in-vitro analysis of azithromycin using electrochemical detection, J PHARM B, 23(6), 2000, pp. 1073-1078
Authors:
Panchagnula, R
Kaur, KJ
Singh, I
Kaul, CL
Citation: R. Panchagnula et al., Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations, METH FIND E, 22(9), 2000, pp. 689-694
Authors:
Kaul, CL
Ramarao, P
Citation: Cl. Kaul et P. Ramarao, Renin release and the sympathetic nervous system, DRUGS TODAY, 36(10), 2000, pp. 699-713
Authors:
Gandhi, R
Kaul, CL
Panchagnula, R
Citation: R. Gandhi et al., Extrusion and spheronization in the development of oral controlled-releasedosage forms, PHARM SCI T, 2(4), 1999, pp. 160-170
Authors:
Kaul, CL
Citation: Cl. Kaul, Role of sympathetic nervous system in experimental hypertension and diabetes mellitus, CLIN EXP HY, 21(1-2), 1999, pp. 95-112
Authors:
Panchagnula, R
Kaur, KJ
Singh, I
Kaul, CL
Citation: R. Panchagnula et al., The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO, INT J TUBE, 3(11), 1999, pp. S336-S342
Authors:
Panchagnula, R
Sood, A
Sharda, N
Kaur, K
Kaul, CL
Citation: R. Panchagnula et al., Determination of rifampicin and its main metabolite in plasma and urine inpresence of pyrazinamide and isoniazid by HPLC method, J PHARM B, 18(6), 1999, pp. 1013-1020
Authors:
Panchagnula, R
Singh, I
Kaur, KJ
Kaul, CL
Citation: R. Panchagnula et al., Bioequivalence study of rifampicin in fixed-dose combination of rifampicinand isoniazid vs. separate formulations, METH FIND E, 21(9), 1999, pp. 625-628
Authors:
Ramarao, P
Kaul, CL
Citation: P. Ramarao et Cl. Kaul, Insulin resistance: Current therapeutic approaches, DRUGS TODAY, 35(12), 1999, pp. 895-911
Authors:
Kaul, CL
Shanthi, K
Bhat, CL
Tickoo, AK
Kaul, RK
Citation: Cl. Kaul et al., AGN detection ranges of MACE and TACTIC imaging gamma-ray telescopes, EXP ASTRON, 8(3), 1998, pp. 187-210
Risultati:
1-14
|